Nebulized Anticholinergic Therapy for Maintenance Treatment of COPD
For patients who have a suboptimal peak inspiratory flow rate and cannot improve breathing with a hand-held inhaler, nebulized anticholinergic therapy for COPD might be an efficient maintenance therapy option. In clinical trials, nebulized glycopyrrolate and revefenacin were well tolerated and did not increase the rate of cardiac-related events.